Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind lot-to-lot consistency trial of V212 in healthy adults
2014-001030-29Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Apr 2014
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of zoster vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Apr 2014; status: terminated.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2014-001030-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001030-29.